ORIC Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, announced that Jacob Chacko, MD, Chief Executive Officer, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019, at 7:30 a.m. PST. The conference will be held at the Westin St. Francis in San Francisco.
About ORIC Pharmaceuticals
ORIC Pharmaceuticals is a priv...